Vimarsana
Biggest News Aggregation in the World

Page 19 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

Ipsen : to present new data at 13th Annual Conference of the International Liver Cancer Association (ILCA 2019) -Today at 10:24 am - Vimarsana News

Ipsen : to present new data at 13th Annual Conference of the International Liver Cancer Association (ILCA 2019) -Today at 10:24 am

Results from a matching-adjusted indirect comparison suggest that cabozantinib provides two additional months of progression-free survival versus regorafenib in the second-line treatment...

EMBER Study: Metformin Use Linked to Vitamin B12 Deficiency - Vimarsana News

EMBER Study: Metformin Use Linked to Vitamin B12 Deficiency

An analysis of data from more than 30,000 people with type 2 diabetes provides insight into the long-term use of metformin and risk of vitamin B12 deficiency.

Enzalutamide Gets Priority Review for nmCSPC With High-Risk BCR - Vimarsana News

Enzalutamide Gets Priority Review for nmCSPC With High-Risk BCR

The FDA has granted priority review to the application for enzalutamide as a treatment for nmCSPC with BCR.

Treatment for Pheochromocytoma, Paraganglioma to Be Discontinued - Vimarsana News

Treatment for Pheochromocytoma, Paraganglioma to Be Discontinued

Progenics Pharmaceuticals will stop producing Azedra (iobenguane I 131) injection due to a lack of commercial demand.

Latest 2023 FDA Approvals - Vimarsana News

Latest 2023 FDA Approvals

FDA approvals include treatments for postpartum depression, RSV in infants, pediatric constipation, metastatic colorectal cancer, and iron deficiency.